Edwards Lifesciences (EW) Non Operating Income (2016 - 2026)
Edwards Lifesciences has reported Non Operating Income over the past 17 years, most recently at $3.2 million for Q4 2025.
- For Q4 2025, Non Operating Income rose 113.91% year-over-year to $3.2 million; the TTM value through Dec 2025 reached $34.0 million, up 21.0%, while the annual FY2025 figure was $7.2 million, 89.55% down from the prior year.
- Non Operating Income for Q4 2025 was $3.2 million at Edwards Lifesciences, up from $2.7 million in the prior quarter.
- Over five years, Non Operating Income peaked at $53.2 million in Q4 2023 and troughed at -$23.0 million in Q4 2024.
- A 5-year average of $7.2 million and a median of $3.8 million in 2022 define the central range for Non Operating Income.
- Biggest five-year swings in Non Operating Income: skyrocketed 1566.67% in 2021 and later tumbled 242.86% in 2022.
- Year by year, Non Operating Income stood at $1.4 million in 2021, then skyrocketed by 314.29% to $5.8 million in 2022, then surged by 817.24% to $53.2 million in 2023, then plummeted by 143.23% to -$23.0 million in 2024, then surged by 113.91% to $3.2 million in 2025.
- Business Quant data shows Non Operating Income for EW at $3.2 million in Q4 2025, $2.7 million in Q3 2025, and -$11.0 million in Q2 2025.